Fujifilm’s Tender Offer For Toyama Chemical Begins (Part 2 Of 2)
This article was originally published in PharmAsia News
Executive Summary
[Editor's Note: This is the second part of a two-part series. Part one covered the specifics of the offer.]
You may also be interested in...
Fujifilm Acquires Two Merck Bio Units Looking To Ramp Up Pharma Business
TOKYO - Fujifilm Corp. plans to acquire two Merck & Co. Inc. biopharma units to make a long-term push into biopharmaceutical manufacturing and distribution, possibly leveraging its pharmaceutical subsidiary, Toyama Chemical, Fuijifilm said
Fujifilm Acquires Two Merck Bio Units Looking To Ramp Up Pharma Business
TOKYO - Fujifilm Corp. plans to acquire two Merck & Co. Inc. biopharma units to make a long-term push into biopharmaceutical manufacturing and distribution, possibly leveraging its pharmaceutical subsidiary, Toyama Chemical, Fuijifilm said
Fujifilm Focuses On Future Of Generics In Japan
Tokyo-based digital imaging maker Fujifilm is venturing further into the pharmaceutical business with the unveiling of the new Fujifilm Pharma, a generic drug joint venture with Mitsubishi and Toho Holdings. The 80-15-5 joint venture aims to start marketing 200 generic drugs starting in April